Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acanthosis nigricans

R A Schwartz1

  • 1New Jersey Medical School, Newark 07103-2714.

Journal of the American Academy of Dermatology
|July 1, 1994
PubMed
Summary
This summary is machine-generated.

Acanthosis nigricans can signal aggressive cancer or indicate a higher risk of insulin resistance and related systemic disorders. This skin condition warrants medical evaluation for underlying health issues.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perineal cutaneous basal cell carcinomas in patients with familial seronegative coeliac disease: report of three cases.

The British journal of dermatology·2021
Same author

Treatment options for leishmaniasis.

Clinical and experimental dermatology·2021
Same author

Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Interdigital syphilis: a rare form of secondary syphilis.

International journal of STD & AIDS·2019
Same author

Prolonged overall survival following metastasectomy in stage IV melanoma.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same author

Declining recommended surgery in primary cutaneous melanoma: an analysis of risk factors and survival.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same journal

Highlights from JAAD Case Reports: September 2026: Repurposing established therapies through biologic insight.

Journal of the American Academy of Dermatology·2026
Same journal

First-Come, First-Served: Ethics of Coordinated Interview Releases.

Journal of the American Academy of Dermatology·2026
Same journal

Ethical Implications of Integrating Artificial Intelligence Tools into Dermatology Electronic Health Records.

Journal of the American Academy of Dermatology·2026
Same journal

Real-world experience with extended deucravacitinib-biologic combination therapy in refractory psoriasis and psoriatic arthritis.

Journal of the American Academy of Dermatology·2026
Same journal

Acute-phase Disease and Super-responder Status Predict Reduced Relapse Risk After Ritlecitinib Withdrawal in Alopecia Areata: A Prospective Real-World Study.

Journal of the American Academy of Dermatology·2026
Same journal

Response to Kvist-Hansen et al. 'Baseline monocytes ≥925/μL appear to represent a rare outlier phenotype rather than a generalizable predictor of adalimumab response in hidradenitis suppurativa.'

Journal of the American Academy of Dermatology·2026
See all related articles

Area of Science:

  • Dermatology
  • Endocrinology
  • Oncology

Background:

  • Acanthosis nigricans presents as a mucocutaneous eruption.
  • It is recognized in two distinct clinical contexts.

Purpose of the Study:

  • To differentiate the implications of acanthosis nigricans.
  • To highlight its association with malignancy and metabolic disorders.

Main Methods:

  • Clinical observation and case review.
  • Histopathological examination.
  • Correlation with internal disease.

Main Results:

  • Exuberant acanthosis nigricans is a marker for highly malignant, rapidly fatal internal cancers.
  • Common acanthosis nigricans indicates increased long-term risk of insulin resistance and compensatory hyperinsulinism.

Conclusions:

  • Acanthosis nigricans has dual significance in clinical diagnosis.
  • Early recognition is crucial for timely intervention in both oncological and metabolic emergencies.